 Home > Active Ingredient News > Immunology News > ARD: Baricitinib in recurrent giant cell arteritis: a 52-week prospective open-label pilot study

ARD: Baricitinib in recurrent giant cell arteritis: a 52-week prospective open-label pilot study

 Last Update: 2022-08-16
 Source: Internet
 Author: User

Tags

amitriptyline 5 mg

cell wall plant

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Objective : Giant cell arteritis ( GCA) is a chronic rheumatic disease with a high recurrence rate during glucocorticoid taperi.

Objectives : Giant cell arteritis ( GCA ) is a chronic rheumatic disease with a high recurrence rate during glucocorticoid taperin.

Methods We conducted a prospective, open-label pilot study of baricitinib ( 4 mg/ day) with graded glucocorticoids ( GC ) and accelerated tapering in patients with recurrent GC.

Results in group 15

patients ( 11 , 73% female), mean age at enrollment was 74 ( SD 2 ) years, median duration of GCA was 9 ( IQR 7-21 ) months, and median previous recurrence was 1 ( 1 -2 ) time.

Conclusions In this proof-of-concept study, baricitinib 4 mg/ day was well tolerated and GC discontinuation was allowed in most patients with recurrent GC.

Source: Koster MJ, Crowson CS, Giblon RE , et a.
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot stu.
Annals of the Rheumatic Diseases2022;81:861-86 , et al Annals of the Rheumatic Diseasesleave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.